biostudies-literatureUnknown9(5)Tanaka NTerumo<h4>Aims/introduction</h4>The present multicenter, cross-sectional survey was initiated to evaluate self-monitoring of blood glucose (SMBG)-associated mental distress among patients with diabetes.<h4>Materials and methods</h4>The survey was carried out in patients with type 1 diabetes and type 2 diabetes using SMBG recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy-related quality of life questionnaires were used to evaluate mood status and health-related quality of life. Two original questionnaires were also developed to evaluate SMBG 'importance,' 'painfulness' and 'confidence' among patients, and to evaluate physician attitudes to SMBG use.<h4>Results</h4>Questionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of tJournal of diabetes investigation1203-1211https://www.ebi.ac.uk/biostudies/studies/S-EPMC6123045biostudies-literatureMental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan.PMC6123045Positive SMBG Study Group InvestigatorsFukuda KYokogawa YIhara YAkashi TSeino YKuroe AYasuda KKouchi YKubota AYamamoto MIwamoto MKagimoto SFujimoto SOida KUeno SYabe DMurotani KTaniguchi TShimono DIkeda HHonjo SNakamura YNakamura SFurukawa MKashii SHamamoto YKurose TSatoh JKadowaki SSekiguchi MShibata TTakahashi NTanaka NUehara ONagayama KMinami MKanamori ANishimura HMatsuura BOsonoi THirota NKuwata HIshitobi MMuro SYokoyama HMatsuoka TNiiya THiraiwa YKawamoto SfalseMental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan.<h4>Aims/introduction</h4>The present multicenter, cross-sectional survey was initiated to evaluate self-monitoring of blood glucose (SMBG)-associated mental distress among patients with diabetes.<h4>Materials and methods</h4>The survey was carried out in patients with type 1 diabetes and type 2 diabetes using SMBG recruited from 42 medical institutions. Profiles of Mood States 2 and diabetes therapy-related quality of life questionnaires were used to evaluate mood status and health-related quality of life. Two original questionnaires were also developed to evaluate SMBG 'importance,' 'painfulness' and 'confidence' among patients, and to evaluate physician attitudes to SMBG use.<h4>Results</h4>Questionnaires from 517 type 1 diabetes and 1,648 type 2 diabetes patients showed that 46.0% of t2018-01-01T00:00:00Z2018 Sep2025-04-22T14:08:23.356Z2019-03-26T23:54:56ZS-EPMC61230452949388110.1111/jdi.12827